Pharmacometrics Markup Language (PharmML): Opening New Perspectives for Model Exchange in Drug Development
Open Access
- 29 May 2015
- journal article
- perspective
- Published by Wiley in CPT: Pharmacometrics & Systems Pharmacology
- Vol. 4 (6) , 316-319
Abstract
The lack of a common exchange format for mathematical models in pharmacometrics has been a long‐standing problem. Such a format has the potential to increase productivity and analysis quality, simplify the handling of complex workflows, ensure reproducibility of research, and facilitate the reuse of existing model resources. Pharmacometrics Markup Language (PharmML), currently under development by the Drug Disease Model Resources (DDMoRe) consortium, is intended to become an exchange standard in pharmacometrics by providing means to encode models, trial designs, and modeling steps.Keywords
Funding Information
- European Union's Seventh Framework Programme (FP7/2007-2013)
This publication has 7 references indexed in Scilit:
- Mixed Effects Models for the Population Approach2014
- Drug and Disease Model Resources: A Consortium to Create Standards and Tools to Enhance Model‐Based Drug DevelopmentCPT: Pharmacometrics & Systems Pharmacology, 2013
- Basic Concepts in Population Modeling, Simulation, and Model‐Based Drug DevelopmentCPT: Pharmacometrics & Systems Pharmacology, 2012
- Pharmacokinetic-Pharmacodynamic Modeling and Simulation2011
- BioModels Database: An enhanced, curated and annotated resource for published quantitative kinetic modelsBMC Systems Biology, 2010
- Standards and ontologies in computational systems biologyEssays in Biochemistry, 2008
- The systems biology markup language (SBML): a medium for representation and exchange of biochemical network modelsBioinformatics, 2003